Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021

Loading...
Loading...

 

Upgrades

  • According to Roth Capital, the prior rating for Seelos Therapeutics Inc SEEL was changed from Neutral to Buy. For the second quarter, Seelos Therapeutics had an EPS of $0.08, compared to year-ago quarter EPS of $0.08. The current stock performance of Seelos Therapeutics shows a 52-week-high of $6.60 and a 52-week-low of $0.56. Moreover, at the end of the last trading period, the closing price was at $2.09.
  • For Yandex NV YNDX, UBS upgraded the previous rating of Neutral to Buy. For the second quarter, Yandex had an EPS of $0.04, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $82.62 and a 52-week-low of $55.62. At the end of the last trading period, Yandex closed at $80.20.
  • SVB Leerink upgraded the previous rating for Sanofi SA SNY from Market Perform to Outperform. Sanofi earned $1.66 in the second quarter, compared to $1.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.26 and a 52-week-low of $44.76. Sanofi closed at $47.94 at the end of the last trading period.
  • According to JMP Securities, the prior rating for Viant Technology Inc DSP was changed from Market Perform to Market Outperform. Interestingly, in the second quarter, Viant Technology's EPS was $0.06. The current stock performance of Viant Technology shows a 52-week-high of $69.16 and a 52-week-low of $11.49. Moreover, at the end of the last trading period, the closing price was at $12.69.
  • JMP Securities upgraded the previous rating for Box Inc BOX from Market Perform to Market Outperform. Box earned $0.21 in the second quarter, compared to $0.18 in the year-ago quarter. The current stock performance of Box shows a 52-week-high of $27.41 and a 52-week-low of $15.07. Moreover, at the end of the last trading period, the closing price was at $25.24.
  • Atlantic Equities upgraded the previous rating for Bath & Body Works Inc BBWI from Neutral to Overweight. In the second quarter, Bath & Body Works earned $1.34.Bath & Body Works closed at $67.39 at the end of the last trading period.
  • For Icon PLC ICLR, JP Morgan upgraded the previous rating of Neutral to Overweight. For the second quarter, Icon had an EPS of $2.12, compared to year-ago quarter EPS of $1.20. At the moment, the stock has a 52-week-high of $284.20 and a 52-week-low of $168.76. Icon closed at $283.04 at the end of the last trading period.
  • For National Instruments Corp NATI, Goldman Sachs upgraded the previous rating of Neutral to Buy. For the second quarter, National Instruments had an EPS of $0.35, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $47.40 and a 52-week-low of $30.42. National Instruments closed at $41.16 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • According to Credit Suisse, the prior rating for Altice USA Inc ATUS was changed from Outperform to Neutral. In the second quarter, Altice USA showed an EPS of $0.51, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $38.30 and a 52-week-low of $19.74. Altice USA closed at $20.58 at the end of the last trading period.
  • B of A Securities downgraded the previous rating for Hyatt Hotels Corp H from Neutral to Underperform. Hyatt Hotels earned $1.15 in the second quarter, compared to $1.80 in the year-ago quarter. The current stock performance of Hyatt Hotels shows a 52-week-high of $92.22 and a 52-week-low of $51.21. Moreover, at the end of the last trading period, the closing price was at $79.76.
  • For American Water Works Co Inc AWK, B of A Securities downgraded the previous rating of Neutral to Underperform. American Water Works Co earned $1.14 in the second quarter, compared to $0.97 in the year-ago quarter. The current stock performance of American Water Works Co shows a 52-week-high of $189.35 and a 52-week-low of $131.01. Moreover, at the end of the last trading period, the closing price was at $176.79.
  • JP Morgan downgraded the previous rating for Talis Biomedical Corp TLIS from Neutral to Underweight. Interestingly, in the second quarter, Talis Biomedical's EPS was $2.51. The stock has a 52-week-high of $33.90 and a 52-week-low of $6.81. At the end of the last trading period, Talis Biomedical closed at $7.04.
  • For Zymergen Inc ZY, JP Morgan downgraded the previous rating of Neutral to Underweight. Interestingly, in the second quarter, Zymergen's EPS was $1.30. The current stock performance of Zymergen shows a 52-week-high of $52.00 and a 52-week-low of $7.85. Moreover, at the end of the last trading period, the closing price was at $13.40.
  • According to Goldman Sachs, the prior rating for Lordstown Motors Corp RIDE was changed from Neutral to Sell. In the second quarter, Lordstown Motors showed an EPS of $0.61, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $31.57 and a 52-week-low of $4.77. At the end of the last trading period, Lordstown Motors closed at $7.57.
  • Raymond James downgraded the previous rating for Altice USA Inc ATUS from Outperform to Market Perform. For the second quarter, Altice USA had an EPS of $0.51, compared to year-ago quarter EPS of $0.19. At the moment, the stock has a 52-week-high of $38.30 and a 52-week-low of $19.74. Altice USA closed at $20.58 at the end of the last trading period.

See all analyst ratings downgrades.

 

Initiations

  • With a Hold rating, Vertical Research initiated coverage on Ecolab Inc ECL. The price target seems to have been set at $189.00 for Ecolab. In the second quarter, Ecolab showed an EPS of $1.22, compared to $0.65 from the year-ago quarter. The current stock performance of Ecolab shows a 52-week-high of $231.25 and a 52-week-low of $181.25. Moreover, at the end of the last trading period, the closing price was at $223.77.
  • With a Buy rating, Craig-Hallum initiated coverage on dMY Technology Group Inc IV DMYQ. The price target seems to have been set at $15.00 for dMY Technology Group Inc. The current stock performance of dMY Technology Group Inc shows a 52-week-high of $10.48 and a 52-week-low of $9.57. Moreover, at the end of the last trading period, the closing price was at $9.95.
  • With a Buy rating, Maxim Group initiated coverage on SPI Energy Co Ltd SPI. The price target seems to have been set at $12.00 for SPI Energy. At the moment, the stock has a 52-week-high of $28.71 and a 52-week-low of $4.59. SPI Energy closed at $5.36 at the end of the last trading period.
  • With a Buy rating, Canaccord Genuity initiated coverage on Pacific Biosciences of California Inc PACB. The price target seems to have been set at $45.00 for Pacific Biosciences. In the second quarter, Pacific Biosciences showed an EPS of $0.21, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $53.69 and a 52-week-low of $8.05. At the end of the last trading period, Pacific Biosciences closed at $25.58.
  • Cantor Fitzgerald initiated coverage on Sierra Oncology Inc SRRA with an Overweight rating. The price target for Sierra Oncology is set to $33.00. For the second quarter, Sierra Oncology had an EPS of $1.41, compared to year-ago quarter EPS of $1.58. The current stock performance of Sierra Oncology shows a 52-week-high of $23.85 and a 52-week-low of $10.02. Moreover, at the end of the last trading period, the closing price was at $22.45.
  • With an Outperform rating, SVB Leerink initiated coverage on UnitedHealth Group Inc UNH. The price target seems to have been set at $480.00 for UnitedHealth Group. In the second quarter, UnitedHealth Group showed an EPS of $4.70, compared to $7.12 from the year-ago quarter. The stock has a 52-week-high of $431.36 and a 52-week-low of $289.64. At the end of the last trading period, UnitedHealth Group closed at $407.08.
  • SVB Leerink initiated coverage on Mednax Inc MD with a Market Perform rating. The price target for Mednax is set to $29.00. Mednax earned $0.41 in the second quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Mednax shows a 52-week-high of $35.67 and a 52-week-low of $12.47. Moreover, at the end of the last trading period, the closing price was at $28.85.
  • With a Market Perform rating, Keefe, Bruyette & Woods initiated coverage on Jackson Financial Inc JXN. The price target seems to have been set at $30.00 for Jackson Financial. In the second quarter, Jackson Financial earned $6.74.  Jackson Financial closed at $27.90 at the end of the last trading period.
  • SVB Leerink initiated coverage on AdaptHealth Corp AHCO with an Outperform rating. The price target for AdaptHealth is set to $30.00. For the second quarter, AdaptHealth had an EPS of $0.17, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $41.58 and a 52-week-low of $19.17. AdaptHealth closed at $23.00 at the end of the last trading period.
  • SVB Leerink initiated coverage on Acadia Healthcare Co Inc ACHC with an Outperform rating. The price target for Acadia Healthcare Co is set to $85.00. In the second quarter, Acadia Healthcare Co showed an EPS of $0.71, compared to $0.54 from the year-ago quarter. The current stock performance of Acadia Healthcare Co shows a 52-week-high of $68.65 and a 52-week-low of $27.07. Moreover, at the end of the last trading period, the closing price was at $65.15.
  • SVB Leerink initiated coverage on Tenet Healthcare Corp THC with a Market Perform rating. The price target for Tenet Healthcare is set to $80.00. For the second quarter, Tenet Healthcare had an EPS of $1.59, compared to year-ago quarter EPS of $1.26. At the moment, the stock has a 52-week-high of $76.16 and a 52-week-low of $21.34. Tenet Healthcare closed at $71.39 at the end of the last trading period.
  • SVB Leerink initiated coverage on Humana Inc HUM with an Outperform rating. The price target for Humana is set to $494.00. Humana earned $6.89 in the second quarter, compared to $12.56 in the year-ago quarter. The current stock performance of Humana shows a 52-week-high of $475.44 and a 52-week-low of $370.22. Moreover, at the end of the last trading period, the closing price was at $398.91.
  • SVB Leerink initiated coverage on Cigna Corp CI with a Market Perform rating. The price target for Cigna is set to $220.00. For the second quarter, Cigna had an EPS of $5.24, compared to year-ago quarter EPS of $5.81. The stock has a 52-week-high of $272.81 and a 52-week-low of $158.84. At the end of the last trading period, Cigna closed at $203.89.
  • SVB Leerink initiated coverage on Amedisys Inc AMED with a Market Perform rating. The price target for Amedisys is set to $170.00. For the second quarter, Amedisys had an EPS of $1.69, compared to year-ago quarter EPS of $1.34. The stock has a 52-week-high of $325.12 and a 52-week-low of $154.52. At the end of the last trading period, Amedisys closed at $155.35.
  • SVB Leerink initiated coverage on HCA Healthcare Inc HCA with an Outperform rating. The price target for HCA Healthcare is set to $320.00. In the second quarter, HCA Healthcare showed an EPS of $4.37, compared to $3.23 from the year-ago quarter. The stock has a 52-week-high of $263.92 and a 52-week-low of $114.38. At the end of the last trading period, HCA Healthcare closed at $256.33.
  • With a Market Perform rating, SVB Leerink initiated coverage on Anthem Inc ANTM. The price target seems to have been set at $403.00 for Anthem. For the second quarter, Anthem had an EPS of $7.03, compared to year-ago quarter EPS of $9.20. The current stock performance of Anthem shows a 52-week-high of $406.00 and a 52-week-low of $244.10. Moreover, at the end of the last trading period, the closing price was at $381.33.
  • With an Outperform rating, SVB Leerink initiated coverage on Agilon Health Inc AGL. The price target seems to have been set at $37.00 for Agilon Health. Agilon Health earned $0.79 in the second quarter. At the moment, the stock has a 52-week-high of $44.83 and a 52-week-low of $26.50. Agilon Health closed at $28.10 at the end of the last trading period.
  • JP Morgan initiated coverage on Omeros Corp OMER with a Neutral rating. The price target for Omeros is set to $15.00. Omeros earned $0.46 in the second quarter, compared to $0.61 in the year-ago quarter. The current stock performance of Omeros shows a 52-week-high of $23.85 and a 52-week-low of $9.25. Moreover, at the end of the last trading period, the closing price was at $15.88.
  • With a Buy rating, Jefferies initiated coverage on Kinnate Biopharma Inc KNTE. The price target seems to have been set at $46.00 for Kinnate Biopharma. Kinnate Biopharma earned $0.49 in the second quarter, compared to $2.05 in the year-ago quarter. The current stock performance of Kinnate Biopharma shows a 52-week-high of $48.75 and a 52-week-low of $17.58. Moreover, at the end of the last trading period, the closing price was at $22.67.
  • With a Neutral rating, JP Morgan initiated coverage on Airbnb Inc ABNB. The price target seems to have been set at $170.00 for Airbnb. For the second quarter, Airbnb had an EPS of $0.11, compared to year-ago quarter EPS of $1.30. The current stock performance of Airbnb shows a 52-week-high of $219.94 and a 52-week-low of $121.50. Moreover, at the end of the last trading period, the closing price was at $175.88.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...